SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Barbo William D

(Last)

(First)

(Middle)

251 BALLARDVALE STREET

(Street)

WILMINGTON

01887

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/18/2016

3. Issuer Name and Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL INC [ CRL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Corporate Executive VP & CCO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock⁽¹⁾	16,465	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (Right to Buy)	02/22/2014⁽²⁾	02/22/2020	Common Stock	2,293	$40.4	D
Stock Options (Right to Buy)	02/28/2015⁽³⁾	02/28/2021	Common Stock	3,650	$59.41	D
Stock Options (Right to Buy)	02/27/2016⁽⁴⁾	02/27/2020	Common Stock	8,631	$76.67	D
Stock Options (Right to Buy)	02/26/2017⁽⁵⁾	02/26/2021	Common Stock	12,060	$73.7	D

Explanation of Responses:

1. Consists of: (a) 9,692 shares of common stock; (b) 2,848 shares of restricted stock which vest as follows: 1,923 shares on 2/22/2017, 462 shares on 2/28/2017 and 463 shares on 2/28/2018; (c) 3,925 unvested restricted stock units (RSUs) which vest as follows: 614 on 2/26/2017, 489 on 2/27/2017, 615 on 2/26/2018, 489 on 2/27/2018, 614 on 2/26/2019, 489 on 2/27/2019 and 615 on 2/26/2020. Each RSU represents a contingent right to receive one share of common stock.

2. Stock Options will vest as follows: 2,293 on 2/22/2017.

3. Stock Options will vest as follows: 1,825 on 2/28/2017 and 1,825 on 2/28/2018.

4. 2,157 stock options have vested as of the reporting date. The remaining 6,474 stock options will vest as follows: 2,158 on 2/27/2017, 2,158 on 2/27/2018 and 2,158 on 2/27/2019.

5. Stock Options will vest in four equal installments of 3,015 on 2/26/2017, 2/26/2018, 2/26/2019 and 2/26/2020.

	/s/ William D. Barbo	10/21/2016
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.